Incisive Genetics: Raises $2.5M in Seed Funding

Incisive Genetics Raises $2.5M in Seed Funding

• Incisive Genetics, a Vancouver BC-based held biotech company, raised $2.5M in seed funding
• The round was led by investors Noel Hall and Sandra MacPherson of the MacHall group and Haig Farris, OC
• The company intends to use the funds to develop its manufacturing process and capabilities, advance key studies to enhance its gene editing delivery platform technology
• Established in 2018 and led by Dr. Blair R. Leavitt, IncisiveGenetics provides a non-viral delivery platform for genetic therapies
• This delivery platform enables a one-step encapsulation of the active CRISPR components within lipid nanoparticles
• The company’s pre-clinical pipeline includes programs addressing neurologic and ocular genetic diseases